Startups
Alex Therapeutics
Alex Therapeutics is a Stockholm digital health company developing therapy companion apps with pharmaceutical partners. It combines cognitive behavioural therapy, patient-centred design and artificial intelligence to support medication adherence, behaviour change and disease-related mental health needs, particularly in rare diseases and oncology. Its products include Almee, a digital anxiety intervention studied in pulmonary fibrosis, and Levilog, a Parkinson’s medication companion app launched with Navamedic in the Nordics in 2025. The company builds indication-specific software and supports its clinical validation and regulated deployment.
Founded 2018